Abingworth’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-259,599
| Closed | -$21.7M | – | 16 |
|
|
2020
Q3 | $21.7M | Sell |
259,599
-259,599
| -50% | -$21.7M | 4.64% | 5 |
|
|
2020
Q2 | $38.1M | Hold |
519,198
| – | – | 10.64% | 4 |
|
|
2020
Q1 | $22M | Hold |
519,198
| – | – | 14.58% | 3 |
|
|
2019
Q4 | $31.6M | Sell |
519,198
-109,200
| -17% | -$6.65M | 15.28% | 3 |
|
|
2019
Q3 | $25.7M | Sell |
628,398
-542,870
| -46% | -$22.2M | 16.28% | 2 |
|
|
2019
Q2 | $55.1M | Hold |
1,171,268
| – | – | 21.11% | 2 |
|
|
2019
Q1 | $41.8M | Hold |
1,171,268
| – | – | 37.43% | 1 |
|
|
2018
Q4 | $33.5M | Sell |
1,171,268
-65,934
| -5% | -$1.88M | 30.41% | 1 |
|
|
2018
Q3 | $54.9M | Hold |
1,237,202
| – | – | 32.61% | 1 |
|
|
2018
Q2 | $72.7M | Sell |
1,237,202
-650,000
| -34% | -$38.2M | 41.53% | 1 |
|
|
2018
Q1 | $86.2M | Sell |
1,887,202
-64,157
| -3% | -$2.93M | 53.59% | 1 |
|
|
2017
Q4 | $45.8M | Sell |
1,951,359
-20,548
| -1% | -$482K | 33.18% | 1 |
|
|
2017
Q3 | $35.1M | Sell |
1,971,907
-472,902
| -19% | -$8.43M | 24.33% | 1 |
|
|
2017
Q2 | $39M | Sell |
2,444,809
-157,005
| -6% | -$2.5M | 31.01% | 1 |
|
|
2017
Q1 | $56.6M | Hold |
2,601,814
| – | – | 42.2% | 1 |
|
|
2016
Q4 | $52M | Buy |
+2,601,814
| New | +$52M | 43.5% | 1 |
|